ProCAncer-I at the European Congress of Radiology 2023

Published on: March 8, 2023
Categories: News

The European Congress of Radiology 2023 took place in Vienna (01-05/03/2023), returning to its traditional spot as a spring meeting. The congress welcomed 17,262 participants from 122 countries. Under the watch of the magnificent golden skull which adorned the congress entrance hall, medical imaging professionals and industry leaders gathered for a meeting marked by cutting-edge science, invaluable education and unforgettable moments. Dr. Papanikolaou presented some early results of ProCAncer-I project regarding “AI modelling strategies with multi-centric data”.

 

Also, the Hacettepe University Hospital gave 3 presentations concerning the developments on monitoring prostate cancer patients, in which ProCAncer-I was also involved:  “Prediction of clinically significant prostate cancer using machine learning models”, “Single-center experience of multiparametric prostate MRI and PI-RADSv2: Exploring the learning curve” and “Long -term follow-uo results of multiparametric prostate MRI and prognostic value of PI-RADSv2″  by Ö. Önder, Y. Yaraşır, V. Gürler, M. Ayva, M. S. Yazici, B. Akdogan, M. Karçaaltincaba, M. N. Özmen, D. Akata.

Highlights

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

ProCAncer-I organised the 4th Dissemination Event of the project at the ECR 2025 held in Vienna, Austria, February 25-26, 2025. During the congress, ProCAncer-I organised a Dedicated Session on the project on the 26th of February 2025, at 15.00-16.00, with the title...

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

Stay in touch!